ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02165215
Brief Title: A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

First Submitted : June 13, 2014
First Submitted that Met QC Criteria : June 16, 2014
First Posted : June 17, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : November 16, 2018
Last Update Posted : November 19, 2018